Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Parallel Group, Controlled Study to Assess the Efficacy and Safety of NMBM in the Treatment of Subjects With a Post-cellulitis and Venous Leg Ulcer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01770509
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:19.609916+00:00
Published At
2017-01-11T00:00:00+00:00
Record Updated At
2017-01-11
Results Posted At
2017-01-11
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Ulcer", "Venous Ulcer", "Skin Ulcer", "Leg Ulcer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-01-11"
protocolSection.identificationModule.nctId
"NCT01770509"
protocolSection.identificationModule.officialTitle
"A Randomized, Parallel Group, Controlled Study to Assess the Efficacy and Safety of NMBM in the Treatment of Subjects With a Post-cellulitis and Venous Leg Ulcer"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-01-11"

Study condition terms

  • Ulcer (protocolSection.conditionsModule.conditions)
  • Venous Ulcer (protocolSection.conditionsModule.conditions)
  • Skin Ulcer (protocolSection.conditionsModule.conditions)
  • Leg Ulcer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.